How does sarcoidosis develop?
An antigen enters the body. It is a foreign molecule that, once inside, activates a whole series of defence mechanisms provided by our innate or acquired immune system.
The activation of these defence mechanisms in response to a foreign body (an antigen) is called a trigger.
The trigger for a viral infection is a virus, for a bacterial infection a bacterium, and for an allergy an allergen.
In sarcoidosis, studies of immune defence mechanisms indicate that the trigger is most likely a bacterium, virus or toxin.
Our immune cells, including macrophages and dendritic cells, present the antigen to the immune system as a danger and release cytokines that activate the immune response.
In sarcoidosis, an unknown reaction occurs: defence cells present information at the site of the antigen that tells the immune system that the body’s own cells are foreign. Inflammation then develops as clusters of immune lymphocytes form granulomas. These granulomas can develop in any organ.
Thus, this inflammatory disease, caused by external factors and genetic predisposition, behaves in some respects like an autoimmune disease.
Modern research links high levels of stress with inflammatory and autoimmune diseases as one possible co-trigger.
Stress raises cortisol levels. If they remain high for too long, this may weaken the immune system. Stress can also damage the body’s own cells and stimulate immune reactions, including increased inflammation, making a person more vulnerable to viruses and infections.
The restoration of normal cortisol production may therefore be linked to an immune reaction that contributes to the development of autoimmune diseases.
Specific biomarkers such as ACE and chitotriosidase, measured in blood, may support a diagnosis of sarcoidosis.
A granuloma biopsy may also show an increased CD4-to-CD8 lymphocyte ratio, supporting the diagnosis of sarcoidosis.
In most people living with sarcoidosis, the lungs are affected. Bilateral hilar lymphadenopathy in the mediastinum may therefore already be visible on an X-ray.
Symptoms may include shortness of breath, fatigue, chest pain and cough.
In most people living with sarcoidosis, the lungs are affected. Bilateral hilar lymphadenopathy in the mediastinum may therefore already be visible on an X-ray.
Symptoms may include shortness of breath, fatigue, chest pain and cough.
A common presentation of pulmonary sarcoidosis is Löfgren syndrome, in which granulomas occur in the lungs, skin and joints. It is also generally considered a more favourable form of sarcoidosis.
Dino-Josip Ključarić, Master of Theology
Additional passages translated from the Croatian article:
In sarcoidosis, studies of defence mechanisms in the immune response have established that the trigger, or cause that sets the disease in motion, is most likely a propionibacterium, virus or toxin.
A granuloma biopsy also reveals a threefold disproportionate ratio of CD4 to CD8 lymphocytes, which confirms the diagnosis of sarcoidosis.
Schematic representation of the causes of sarcoidosis at the cellular level
How sarcoidosis develops and progresses at the cellular level
In simple terms:
1. A foreign body enters the body.
This body is called an antigen.
It most likely enters through the airways.
2. The immune system responds “too aggressively.”
Small cells called macrophages are responsible for “eating” foreign material. Together, they form an inflammatory cluster and create granulomas.
During the defence process, these macrophages may contribute to calcification of healthy tissue. For this reason:
DO NOT TAKE CALCIUM OR VITAMIN D WITHOUT MEDICAL SUPERVISION, AND DO NOT TRY TO BOOST THE IMMUNE SYSTEM.
Lymphatic vessels, whose role is to remove toxins and reduce inflammation, become swollen as they encounter granulomas.
Treatment with glucocorticosteroids aims to reduce inflammation, while treatment with cytotoxic or immunosuppressive medicines such as methotrexate slows the immune response.
Exposure to an unknown sarcoidosis antigen activates T cells and antigen-presenting cells (APCs), leading to the release of cytokines.
CD4 activation can skew the immune system towards a Th1 or Th2 response, which in turn induces granuloma formation.
At later stages, granuloma formation may be followed by resolution or by a chronic state of disease with fibrosis.
A granuloma is a term used to describe a type of inflammation that occurs in response to different triggers, such as infections, foreign bodies or autoimmune disorders.
It is characterised by small clusters of cells that may develop in different parts of the body, including the lungs, skin and digestive system.
Granulomas consist of immune cells, such as macrophages, which accumulate in a particular area in response to a stimulus.
Sarcoid granuloma:
It can develop in several organs, including the lungs, lymph nodes and skin. The cause of sarcoidosis is not fully understood, but it is believed to involve an abnormal immune response in which the immune system attacks the body’s own tissues. Sarcoid granulomas can cause symptoms such as cough, breathing difficulties and skin lesions.
Macrophages are a type of leukocyte found in humans and animals. They are microscopically larger than neutrophils and their main task is to clear waste from the body and fight foreign substances (antigens).
They develop from blood monocytes, which are produced in the bone marrow, and have characteristic morphological features. Unfortunately, macrophages contribute to anthracosis and asbestosis because they move towards inflammatory interleukins, such as IL-1, and areas of inflammation, where they “eat” (Greek phagein, “to eat”) foreign particles. This can lead to pulmonary anthracosis when the material cannot be broken down. Macrophages also participate in atherosclerosis, where they become “foam cells”. They are present in many organs. Their main function is to engulf foreign substances, a process called phagocytosis.
TNF-alpha
Macrophages release plasminogen activator, which is important in blood clotting. They also release serine proteases, other enzymes, various interleukins and tumour necrosis factor alpha (TNF-alpha).
Dino-Josip Ključarić, Master of Theology
Work ability of a forklift operator diagnosed with sarcoidosis
Translation of the source article (2021)
Faithful English translation of Renata Ecimović Nemarnik’s article ‘Radna sposobnost rukovatelja viličarem kod kojeg je otkrivena sarkoidoza’, published in Sigurnost 63(3), 335–337 (2021). The Croatian original is retained unchanged. The source is published under CC BY 4.0; the change made here is translation into English. Historical medical statements are reproduced without updating or independent endorsement. This translation is not individualized clinical or fitness-for-work advice.
Source: Renata Ecimović Nemarnik (2021). RADNA SPOSOBNOST RUKOVATELJA VILIČAREM KOD KOJEG JE OTKRIVENA SARKOIDOZA. Sigurnost, 63(3), 335–337. Original article (Croatian PDF). License: CC BY 4.0.
Introduction
Sarcoidosis is a rare disease that threatens the working population between the ages of 20 and 40. It occurs as an inflammatory response to external factors in genetically susceptible individuals. Although this has not been proven, possible triggers of the disease include viral, bacterial and mycobacterial infections, and inhaled inorganic substances (e.g. aluminium, zirconium, talc) or organic substances (e.g. pine pollen, clay). The disease develops when an unknown antigen triggers a cellular immune response that leads to the accumulation of T lymphocytes and macrophages, the release of cytokines and chemokines, and the organization of the relevant cells into granulomas. Granulomas most commonly develop in the lungs and lymph nodes, but can also be found at many other sites, including the liver, spleen, eyes, skin, bones, joints, skeletal muscles, kidneys, reproductive organs, heart, salivary glands and nervous system. Sarcoidosis should be suspected when hilar adenopathy is found incidentally on a chest X-ray. Laboratory tests play a role in diagnosis and in assessing the extent of involvement of other organs; for example, a blood count, electrolytes (calcium), urea, creatinine and liver function tests usually provide useful information for detecting extrathoracic sarcoidosis. Serum ACE levels can be used to monitor disease activity and the response to treatment in cases of confirmed sarcoidosis.
In a large number of cases, the disease resolves spontaneously (90% of cases), making the decision about treatment more difficult. In any event, treatment is necessary for progressive pulmonary, ocular and cardiac disease. Corticosteroids are the mainstay of treatment. Around 10% of patients develop serious impairment of ocular, pulmonary or some other organ function, but mortality from sarcoidosis is less than 3%. Pulmonary fibrosis, which leads to respiratory and heart failure, is the most common cause of death.
The prognosis is worse for extrapulmonary sarcoidosis. Favourable prognostic signs are erythema nodosum and acute arthritis. Uveitis, lupus, chronic hypercalcaemia, neurosarcoidosis, nephrocalcinosis, myocardial disease and extensive pulmonary disease are poor prognostic signs.
Loss of work ability can result from impaired vision and diseases of the respiratory system and heart, and is thought to occur in 10% of those affected. Around 50% of people who have had sarcoidosis experience recurrences of the disease. Although it is a rare disease, sarcoidosis can affect work ability because of its many symptoms and possible more severe outcomes, so it needs to be detected in time, monitored and treated as necessary.
Case report
A 31-year-old patient with a secondary-level vocational qualification works as a forklift operator and has a total of 10 years of employment. He was diagnosed with sarcoidosis two years ago. The sarcoidosis affected his lungs, spleen, eyes and lymph nodes in the mediastinum, groin and neck. To date, he has had no occupational injuries or confirmed occupational diseases. He had a period of temporary incapacity for work lasting 14 days because of uveitis associated with sarcoidosis.
Because of a persistent cough after recovering from bronchitis, the patient was referred for a chest X-ray, which revealed hilar adenopathy, and because of redness of the eyes he was referred for an ophthalmological examination. The ophthalmological assessment indicated uveitis associated with sarcoidosis. Further diagnostic investigations were performed because sarcoidosis might involve several organs. Laboratory investigations showed leukopenia, the 24-hour urine findings showed nephrocalcinosis, and abdominal ultrasound showed splenomegaly with enlarged mediastinal, abdominal and inguinal lymph nodes.
The patient was prescribed treatment with Decortin, together with protection of the gastric mucosa and regular follow-up examinations every 4 months, and was instructed to attend the respiratory outpatient clinic for an examination if new symptoms developed or existing symptoms worsened. At follow-up examinations, the patient showed satisfactory improvement in the disease, normalization of laboratory results, regression of uveitis and recovery of the white blood cell lineage, indicating that the disease was under control. He underwent regular abdominal ultrasound examinations because of the enlarged spleen and lymph nodes. Decortin treatment was reduced to a maintenance dose. The patient was advised to avoid sun exposure.
At examinations in the occupational and sports medicine outpatient clinic, the patient regularly brought the results of his follow-up examinations, felt well and had no symptoms that would prevent him from performing his work duties. No pathological changes were found on clinical examination, laboratory results were within normal limits, and the results of spirometry, audiometry and ECG were also within normal limits. Because of the ocular changes he had experienced in association with sarcoidosis, he was referred for a follow-up examination by an ophthalmologist.
The ophthalmological findings on slit-lamp examination showed that the eyes were now free of irritation, with synechiae present in the left eye at the 8, 10 and 12 o’clock positions. Gonioscopy revealed peripheral anterior adhesions. Fundus examination showed a clear vitreous without inflammatory elements, and a few small atrophic spots were present in the lower part of the fundus. As there were no longer any inflammatory changes in the eyes, the patient was scheduled for a follow-up examination in three months.
Discussion and conclusion
The true causes of pulmonary sarcoidosis are still unknown. Some scientists believe that it is a genetic disease, while others believe that it is a disease of the immune system. There are also theories that pulmonary sarcoidosis develops because of a biochemical disorder in the body. Most scientists believe that a combination of these factors causes pulmonary sarcoidosis to develop, although no theory confirms the nature of the disease’s origin. Infectious disease specialists maintain that protozoa, Histoplasma, spirochaetes, fungi, mycobacteria and other microorganisms can cause pulmonary sarcoidosis, as can numerous endogenous and exogenous factors that may cause the disease to develop. It is therefore generally accepted today that sarcoidosis is associated with biochemical, morphological and immunological disorders and a genetic component.
An interesting observation is that a higher incidence of sarcoidosis has been seen in certain occupations, such as firefighters (because of increased toxic or infectious effects), mechanics, sailors, millers, farmers, postal workers, and workers in chemical manufacturing and healthcare. These occupations are directly or indirectly associated with lung damage. Substances that are hazardous to health can trigger this disease; these include poisons, toxins, chemicals and dust. This may be why workers in these occupations develop sarcoidosis much faster than people in other professions. Pulmonary sarcoidosis is also observed in people who are dependent on tobacco. The presence of an allergic reaction to certain substances that the body perceives as foreign because of impaired immune reactivity can also lead to pulmonary sarcoidosis.
The most common severe consequences of this disease include the development of respiratory failure, cor pulmonale, pulmonary emphysema and bronchial obstructive syndrome. The following are considered indicators of a poor prognosis with severe consequences: African-American origin of the patient, adverse environmental conditions, a prolonged period of elevated temperature (more than one month) at the onset of the disease, simultaneous damage to several organs and systems (generalized form), and relapse (return of acute symptoms) after completion of corticosteroid treatment.
Sarcoidosis without complications does not substantially affect work ability, so regular patient monitoring and the implementation of preventive measures to prevent possible complications are important. Preventing complications of the disease includes limiting exposure to factors that could cause sarcoidosis, namely environmental factors that can enter the body through inhaled air. Patients are advised to ventilate the spaces they occupy regularly and to use wet cleaning to avoid airborne dust and mould. In addition, avoiding prolonged sun exposure and stress is recommended because these lead to disturbances of metabolic processes in the body and increased growth of granulomas. Preventive measures also include avoiding hypothermia, as this can contribute to bacterial infections through worsening of lung ventilation and weakening of the immune system.
Since uveitis in our worker did not affect visual acuity, the patient was able to work normally with ophthalmological follow-up every three months and respiratory follow-up every 4 months. There was regression of the disease, normalization of laboratory results, regression of uveitis and recovery of the white blood cell lineage. The dose of Decortin was also reduced. In most cases, this is a disease that will not substantially affect an employee’s work ability, and preventive examinations by the relevant specialists and regular follow-up examinations make it possible to prevent further potential complications of the disease through timely treatment.
Author and qualifications as published: Renata Ecimović Nemarnik, dr. med., univ. mag. med., spec. obitelj. med., spec. med. rada i sporta
Affiliation as published: Zagreb West Health Centre (Dom zdravlja Zagreb Zapad), Zagreb
Translation notes
- Editorial notes, separate from the translated article: the author’s Croatian credential abbreviations are retained to avoid implying equivalence with qualifications in another country.
- The word ‘lupus’ is translated literally; the source does not specify a subtype.
- The source reports nephrocalcinosis in the 24-hour urine findings. This wording is retained without substituting hypercalciuria or inferring a different investigation.
- Clay remains among the examples of organic substances because that is how it is classified in the source.